In lung cancer, depletion of NFS1 in combination with cysteine transport inhibition disrupts ISCs, inducing ferroptosis and impairing tumor growth, and may represent a potential therapeutic intervention by targeting NFS1 [41]. This evidence concerns the gene NFS1 and lung carcinoma.